Cargando…

MicroRNA-181a promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma via the TGF-β/Smad pathway

Esophageal squamous cell carcinoma (ESCC) is one of the most debilitating and invasive tumors. Although previous reports have demonstrated the critical role microRNA-181a (miR-181a) serves in the progression of ESCC, how miR-181a induces epithelial-mesenchymal transition (EMT) remains to be elucidat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Run, Zhou, Xue-Mei, Li, Yu-Shan, Ren, Li, He, Xin-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974267/ https://www.ncbi.nlm.nih.gov/pubmed/33760133 http://dx.doi.org/10.3892/mmr.2021.11955

Ejemplares similares

MicroRNA-182 targets SMAD7 to potentiate TGFβ-induced epithelial-mesenchymal transition and metastasis of cancer cells
por: Yu, Jingyi, et al.
Publicado: (2016)

Repression of Smad4 by MicroRNA-1285 moderates TGF-β-induced epithelial–mesenchymal transition in proliferative vitreoretinopathy
por: Pao, Shu-I, et al.
Publicado: (2021)

RUNX3 inhibits the invasion and migration of esophageal squamous cell carcinoma by reversing the epithelial-mesenchymal transition through TGF-β/Smad signaling
por: Xiao, Zhaohua, et al.
Publicado: (2020)

MicroRNA-122 inhibits epithelial-mesenchymal transition of hepatic stellate cells induced by the TGF-β1/Smad signaling pathway
por: Cheng, Bianqiao, et al.
Publicado: (2019)

microRNA-141 inhibits TGF-β1-induced epithelial-to-mesenchymal transition through inhibition of the TGF-β1/SMAD2 signalling pathway in endometriosis
por: Wang, Sixue, et al.
Publicado: (2020)

Thalidomide Inhibits TGF-β1-induced Epithelial to Mesenchymal Transition in Alveolar Epithelial Cells via Smad-Dependent and Smad-Independent Signaling Pathways
por: Zhou, Xian-Long, et al.
Publicado: (2017)

MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: WANG, SHENGJIE, et al.
Publicado: (2019)

MicroRNA-485-5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin-1 and inhibits the epithelial-mesenchymal transition
por: Zhao, Riyang, et al.
Publicado: (2021)

[Corrigendum] MicroRNA-133b targets TGFβ receptor I to inhibit TGF-β-induced epithelial-to-mesenchymal transition and metastasis by suppressing the TGF-β/SMAD pathway in breast cancer
por: Wang, Shengjie, et al.
Publicado: (2023)

MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGFβ1/Smad2 signaling pathway in human bladder cancer
por: Wei, Xi Chao, et al.
Publicado: (2019)

microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial–mesenchymal transition
por: Parikh, Aditya, et al.
Publicado: (2014)

CDCA7 promotes TGF‐β‐induced epithelial–mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC
por: Li, Hongyi, et al.
Publicado: (2022)

MicroRNA-23a regulates epithelial-to-mesenchymal transition in endometrial endometrioid adenocarcinoma by targeting SMAD3
por: Liu, Ping, et al.
Publicado: (2016)

MicroRNA Regulation of Epithelial to Mesenchymal Transition
por: Abba, Mohammed L., et al.
Publicado: (2016)

microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
por: Qiao, Pengfei, et al.
Publicado: (2015)

MicroRNA-145 suppresses epithelial to mesenchymal transition in pancreatic cancer cells by inhibiting TGF-β signaling pathway
por: Chen, Shaojun, et al.
Publicado: (2020)

Bleomycin (BLM) Induces Epithelial-to-Mesenchymal Transition in Cultured A549 Cells via the TGF-β/Smad Signaling Pathway
por: Chen, Kui-Jun, et al.
Publicado: (2016)

TGF-β1/Smad Signaling Pathway Regulates Epithelial-to-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma: In Vitro and Clinical Analyses of Cell Lines and Nomadic Kazakh Patients from Northwest Xinjiang, China
por: Pang, Lijuan, et al.
Publicado: (2014)

Loss of N-Myc interactor promotes epithelial-mesenchymal-transition by activation of TGF-β/SMAD signaling
por: Devine, Daniel J., et al.
Publicado: (2013)

Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis
por: Bu, Wenhuan, et al.
Publicado: (2019)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

Epithelial-to-Mesenchymal Transition and MicroRNAs in Lung Cancer
por: Legras, Antoine, et al.
Publicado: (2017)

Expression of proteins associated with epithelial-mesenchymal transition in esophageal squamous cell carcinoma
por: Zhang, Tian, et al.
Publicado: (2018)

Aberrant methylation of EYA4 promotes epithelial‐mesenchymal transition in esophageal squamous cell carcinoma
por: Luo, Mei, et al.
Publicado: (2018)

MicroRNA-199b-5p attenuates TGF-β1-induced epithelial–mesenchymal transition in hepatocellular carcinoma
por: Zhou, Shao-jun, et al.
Publicado: (2017)

Effects of cisatracurium on epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma
por: Lv, Wenyan, et al.
Publicado: (2019)

GOLM1 Promotes Epithelial-Mesenchymal Transition by Activating TGFβ1/Smad2 Signaling in Prostate Cancer
por: Qin, Xuke, et al.
Publicado: (2023)

MicroRNA-92b inhibits epithelial-mesenchymal transition-induced migration and invasion by targeting Smad3 in nasopharyngeal cancer
por: Zhao, Chong, et al.
Publicado: (2017)

MicroRNA-10b regulates epithelial–mesenchymal transition by modulating KLF4/KLF11/Smads in hepatocellular carcinoma
por: Hujie, Gulibaha, et al.
Publicado: (2018)

MicroRNA-32-5p inhibits epithelial-mesenchymal transition and metastasis in lung adenocarcinoma by targeting SMAD family 3
por: Zhang, Jin-Xing, et al.
Publicado: (2021)

Disulfiram inhibits epithelial–mesenchymal transition through TGFβ–ERK–Snail pathway independently of Smad4 to decrease oral squamous cell carcinoma metastasis [Corrigendum]
por: Bu, Wenhuan, et al.
Publicado: (2019)

Silencing of Long Non-coding RNA SMAD5-AS1 Reverses Epithelial Mesenchymal Transition in Nasopharyngeal Carcinoma via microRNA-195-Dependent Inhibition of SMAD5
por: Li, Siwei, et al.
Publicado: (2019)

Sildenafil Inhibits the Growth and Epithelial-to-mesenchymal Transition of Cervical Cancer via the TGF-β1/Smad2/3 Pathway
por: Liu, Ping, et al.
Publicado: (2023)

Baicalin and puerarin reverse epithelial-mesenchymal transition via the TGF-β1/Smad3 pathway in vitro
por: Wu, Tao, et al.
Publicado: (2018)

Suppression of AGR2 in a TGF-β-induced Smad regulatory pathway mediates epithelial-mesenchymal transition
por: Sommerova, Lucia, et al.
Publicado: (2017)

Possible involvement of TGF-β-SMAD-mediated epithelial-mesenchymal transition in pro-metastatic property of PAX6
por: Jin, Meng, et al.
Publicado: (2020)

Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer
por: Chen, Hsin-Yuan, et al.
Publicado: (2021)

SUMOylation of Smad2 mediates TGF-β-regulated endothelial–mesenchymal transition
por: Su, Qi, et al.
Publicado: (2023)

DNA-PKcs Mediates An Epithelial-Mesenchymal Transition Process Promoting Cutaneous Squamous Cell Carcinoma Invasion And Metastasis By Targeting The TGF-β1/Smad Signaling Pathway
por: Zhang, Juan, et al.
Publicado: (2019)

DcR3 induces epithelial-mesenchymal transition through activation of the TGF-β3/SMAD signaling pathway in CRC
por: Liu, Yan-Ping, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0r7mqh3optoc0bdc8crglgl7e2